4//SEC Filing
Pelizzon David R 4
Accession 0000899243-22-028657
CIK 0001425450other
Filed
Aug 14, 8:00 PM ET
Accepted
Aug 15, 5:38 PM ET
Size
6.3 KB
Accession
0000899243-22-028657
Insider Transaction Report
Form 4
Pelizzon David R
Director
Transactions
- Purchase
Warrants (right to buy)
2022-08-11$55.00/sh+1,525,000$83,874,695→ 1,525,000 total(indirect: See footnote)Exercise: $0.00→ Common Stock (1,525,000 underlying)
Footnotes (2)
- [F1]Squadron Capital LLC ("Squadron") beneficially owns shares of the Issuer's common stock with a market value in excess of the notification threshold of the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended (the "HSR Act"). The warrants may not be exercised until the expiration of all applicable HSR Act waiting periods or the exercise otherwise becomes exempt from the notification requirements thereunder. Once the warrants become exercisable, Squadron is obligated to exercise them within five (5) business days.
- [F2]These securities are held directly by Squadron. As the President and a member of the Managing Committee of Squadron, the reporting person may be deemed to be the beneficial owner of these securities. The reporting person expressly disclaims beneficial ownership of these securities, except to the extent of his pecuniary interest therein. The inclusion of these securities in this report shall not be deemed to be an admission of beneficial ownership for purposes of Section 16 or for any other purpose.
Documents
Issuer
ORTHOPEDIATRICS CORP
CIK 0001425450
Entity typeother
Related Parties
1- filerCIK 0001719217
Filing Metadata
- Form type
- 4
- Filed
- Aug 14, 8:00 PM ET
- Accepted
- Aug 15, 5:38 PM ET
- Size
- 6.3 KB